Stocks-TECH-Bio-Techne Corp

TECH Bio-Techne Corp

73.33 0.85 (1.17%)
Market OpenDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 30/6/2023: Bio-Techne Corp's revenues increased by 2.81% and amounted to 1.14B. Net income increased by 8.49% to 285.44M. Net assets increased by 15.61% to 1.97B and EPS decreased from 6.63 to 1.76.
TECH's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
67.72%
Net Profit Margin
21.84%
Operating Margin
24.67%
Return On Investment
10.23%